The high-resolution solar reference spectrum between 250 and 550 nm and its application to measurements with the ozone monitoring instrument

We have constructed a new high resolution solar reference spectrum in the spectral range between 250 and 550 nm. The primary use of this spectrum is for the calibration of the Dutch¿-¿Finnish Ozone Monitoring Instrument (OMI), but other applications are mentioned. The incentive for deriving a new high resolution solar reference spectrum is that available spectra do not meet our requirements on radiometric accuracy or spectral resolution. In this paper we explain the steps involved in constructing the new spectrum, based on available low and high resolution spectra and discuss the main sources of uncertainty. We compare the result with solar measurements obtained with the OMI as well as with other UV-VIS space-borne spectrometers with a similar spectral resolution. We obtain excellent agreement with the OMI measurements, which indicates that both the newly derived solar reference spectrum and our characterization of the OMI instrument are well understood. We also find good agreement with previously published low resolution spectra. The absolute intensity scale, wavelength calibration and representation of the strength of the Fraunhofer lines have been investigated and optimized to obtain the resulting high resolution solar reference spectrum. © 2008 Springer Science+Business Media B.V. U7 - Export Date: 2 August 2010 U7 - Source: Scopu

From ozone monitoring instrument (OMI) to tropospheric monitoring instrument (TROPOMI)

The OMI instrument is an ultraviolet-visible imaging spectrograph that uses two-dimensional CCD detectors to register both the spectrum and the swath perpendicular to the flight direction with a 115° wide swath, which enables global daily ground coverage with high spatial resolution. This paper presents a selection of in-flight radiometric and CCD detector calibration and performance monitoring results since the launch in July 2004. From these examples it will be shown that OMI is performing very well after more than four years in orbit. It is shown how the OMI irradiance measurement data have been used to derive a high resolution solar reference spectrum with good radiometric calibration, good wavelength calibration and high spectral sampling. The surface reflectance climatology derived from three years of in-orbit OMI measurement data is presented and discussed. The OMI mission may possibly be extended in 2009 for another two or four years, depending on the performance of the instrument. By 2013-2014 OMI on EOS-Aura and SCIAMACHY on ENVISAT will have reached more that twice their anticipated lifetimes. In order to guarantee continuity of Earth atmosphere tropospheric and climate measurement data new instrumentation shall be available around that time. A successor of OMI and SCIAMACHY, named TROPOspheric Monitoring Instrument (TROPOMI), scheduled for launch by the end of 2013, is discussed in this paper

TeV Gamma-ray Observations of the Crab and Mkn 501 during Moonshine and Twilight

TeV Gamma-ray signals from the Crab Nebula and Mkn 501 were detected with the HEGRA CT1 imaging Cerenkov telescope during periods when the moon was shining and during twilight. This was accomplished by lowering the high voltage supply of the photomutipliers in fixed steps up to 13%. No other adjustments were made and no filters were used. Laser runs could not establish any non-linearity in the gain of the individual pixels, and the trigger rate was uniform over the whole camera. The energy threshol was increased by up to a factor of two, depending on the amount of HV reduction. In a series of observations lasting 11.7 hours, a signal with a 3.4 sigma significance was detected from the Crab. During the 1997 multiple flare episode of Mkn 501 a 26 sigma combined excess has been recorded during 134 hours of observations under various moonshine/twilight conditions. The results show that this technique can easily be adapted to increase the exposure of a source, which is important for sources showing rapid time variability such as AGNs or GRBs. Observations can be made up to ~20 deg. angular separation from the moon and until the moon is 85% illuminated (ten to eleven days before and after new moon), as well as during 20 to 40 minutes during twilight, before the commencement of astronomical darkness.Comment: 16 pages, 5 figures, submitted to Astroparticle Physic

Neonatal Colonisation Expands a Specific Intestinal Antigen-Presenting Cell Subset Prior to CD4 T-Cell Expansion, without Altering T-Cell Repertoire

Interactions between the early-life colonising intestinal microbiota and the developing immune system are critical in determining the nature of immune responses in later life. Studies in neonatal animals in which this interaction can be examined are central to understanding the mechanisms by which the microbiota impacts on immune development and to developing therapies based on manipulation of the microbiome. The inbred piglet model represents a system that is comparable to human neonates and allows for control of the impact of maternal factors. Here we show that colonisation with a defined microbiota produces expansion of mucosal plasma cells and of T-lymphocytes without altering the repertoire of alpha beta T-cells in the intestine. Importantly, this is preceded by microbially-induced expansion of a signal regulatory protein α-positive (SIRPα+) antigen-presenting cell subset, whilst SIRPα−CD11R1+ antigen-presenting cells (APCs) are unaffected by colonisation. The central role of intestinal APCs in the induction and maintenance of mucosal immunity implicates SIRPα+ antigen-presenting cells as orchestrators of early-life mucosal immune development

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

Lenalidomide has been proven to be effective but with a distinct and difficult to manage toxicity profile in the context of chronic lymphocytic leukemia, potentially hampering combination treatment with this drug. We conducted a phase 1-2 study to evaluate the efficacy and safety of six cycles of chlorambucil (7 mg/m2 daily), rituximab (375 mg/m2 cycle 1 and 500 mg/m2 cycles 2-6) and individually-dosed lenalidomide (escalated from 2.5 mg to 10 mg) (induction-I) in first-line treatment of patients with chronic lymphocytic leukemia unfit for treatment with fludarabine, cyclophosphamide and rituximab. This was followed by 6 months of 10 mg lenalidomide monotherapy (induction-II). Of 53 evaluable patients in phase 2 of the study, 47 (89%) completed induction-I and 36 (68%) completed induction-II. In an intention-to-treat analysis, the overall response rate was 83%. The median progression-free survival was 49 months, after a median follow-up time of 27 months. The 2- and 3-year progression-free survival rates were 58% and 54%, respectively. The corresponding rates for overall survival were 98% and 95%. No tumor lysis syndrome was observed, while tumor flair reaction occurred in five patients (9%, 1 grade 3). The most common hematologic toxicity was grade 3-4 neutropenia, which occurred in 73% of the patients. In conclusion, addition of lenalidomide to a chemotherapy backbone followed by a fixed duration of lenalidomide monotherapy resulted in high remission rates and progression-free survival rates, which seem comparable to those observed with novel drug combinations including novel CD20 monoclonal antibodies or kinase inhibitors. Although lenalidomide-specific toxicity remains a concern, an individualized dose-escalation schedule is feasible and results in an acceptable toxicity profile. EuraCT number: 2010-022294-34

New Era of Air Quality Monitoring from Space: Geostationary Environment Monitoring Spectrometer (GEMS)

GEMS will monitor air quality over Asia at unprecedented spatial and temporal resolution from GEO for the first time, providing column measurements of aerosol, ozone and their precursors (nitrogen dioxide, sulfur dioxide and formaldehyde). Geostationary Environment Monitoring Spectrometer (GEMS) is scheduled for launch in late 2019 - early 2020 to monitor Air Quality (AQ) at an unprecedented spatial and temporal resolution from a Geostationary Earth Orbit (GEO) for the first time. With the development of UV-visible spectrometers at sub-nm spectral resolution and sophisticated retrieval algorithms, estimates of the column amounts of atmospheric pollutants (O3, NO2, SO2, HCHO, CHOCHO and aerosols) can be obtained. To date, all the UV-visible satellite missions monitoring air quality have been in Low Earth orbit (LEO), allowing one to two observations per day. With UV-visible instruments on GEO platforms, the diurnal variations of these pollutants can now be determined. Details of the GEMS mission are presented, including instrumentation, scientific algorithms, predicted performance, and applications for air quality forecasts through data assimilation. GEMS will be onboard the GEO-KOMPSAT-2 satellite series, which also hosts the Advanced Meteorological Imager (AMI) and Geostationary Ocean Color Imager (GOCI)-2. These three instruments will provide synergistic science products to better understand air quality, meteorology, the long-range transport of air pollutants, emission source distributions, and chemical processes. Faster sampling rates at higher spatial resolution will increase the probability of finding cloud-free pixels, leading to more observations of aerosols and trace gases than is possible from LEO. GEMS will be joined by NASA's TEMPO and ESA's Sentinel-4 to form a GEO AQ satellite constellation in early 2020s, coordinated by the Committee on Earth Observation Satellites (CEOS)